Here, we tested the predictive value of BCL2 family expression levels for BC patient survival in a patient cohort with detailed clinical follow-up and investigated the biological significance of the NOXA/MCL1 axis for MCD in BC cell lines exposed to paclitaxel and BH3 mimetics. This evidence concerns the gene BCL2 and breast cancer.